• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去中心化的耐多药结核病护理:系统评价和荟萃分析。

Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis.

机构信息

Woolcock Institute of Medical Research, University of Sydney, 431 Glebe Point Road, Glebe, New South Wales 2037, Australia.

Global TB Programme, World Health Organization, Geneva, Switzerland.

出版信息

Bull World Health Organ. 2017 Aug 1;95(8):584-593. doi: 10.2471/BLT.17.193375.

DOI:10.2471/BLT.17.193375
PMID:28804170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5537756/
Abstract

OBJECTIVE

To assess the effectiveness of decentralized treatment and care for patients with multidrug-resistant (MDR) tuberculosis, in comparison with centralized approaches.

METHODS

We searched ClinicalTrials.gov, the Cochrane library, Embase®, Google Scholar, LILACS, PubMed®, Web of Science and the World Health Organization's portal of clinical trials for studies reporting treatment outcomes for decentralized and centralized care of MDR tuberculosis. The primary outcome was treatment success. When possible, we also evaluated, death, loss to follow-up, treatment adherence and health-system costs. To obtain pooled relative risk (RR) estimates, we performed random-effects meta-analyses.

FINDINGS

Eight studies met the eligibility criteria for review inclusion. Six cohort studies, with 4026 participants in total, reported on treatment outcomes. The pooled RR estimate for decentralized versus centralized care for treatment success was 1.13 (95% CI: 1.01-1.27). The corresponding estimate for loss to follow-up was RR: 0.66 (95% CI: 0.38-1.13), for death RR: 1.01 (95% CI: 0.67-1.52) and for treatment failure was RR: 1.07 (95% CI: 0.48-2.40). Two of three studies evaluating health-care costs reported lower costs for the decentralized models of care than for the centralized models.

CONCLUSION

Treatment success was more likely among patients with MDR tuberculosis treated using a decentralized approach. Further studies are required to explore the effectiveness of decentralized MDR tuberculosis care in a range of different settings.

摘要

目的

评估与集中式方法相比,为耐多药(MDR)肺结核患者提供分散式治疗和护理的效果。

方法

我们在 ClinicalTrials.gov、Cochrane 图书馆、Embase®、Google Scholar、LILACS、PubMed®、Web of Science 和世界卫生组织临床试验门户中检索了报告 MDR 肺结核分散式和集中式护理治疗结果的研究。主要结局是治疗成功。在可能的情况下,我们还评估了死亡、失访、治疗依从性和卫生系统成本。为了获得汇总相对风险(RR)估计值,我们进行了随机效应荟萃分析。

发现

有 8 项研究符合综述纳入标准。6 项队列研究共纳入 4026 名参与者,报告了治疗结果。与集中式护理相比,分散式护理的治疗成功率的汇总 RR 估计值为 1.13(95%CI:1.01-1.27)。失访的相应 RR 估计值为 0.66(95%CI:0.38-1.13),死亡的 RR 估计值为 1.01(95%CI:0.67-1.52),治疗失败的 RR 估计值为 1.07(95%CI:0.48-2.40)。评估卫生保健成本的三项研究中有两项报告,分散式护理模式的成本低于集中式护理模式。

结论

采用分散式方法治疗的 MDR 肺结核患者更有可能治疗成功。需要进一步研究以探索在各种不同环境下分散式 MDR 肺结核护理的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c92b/5537756/95d1b253a485/BLT.17.193375-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c92b/5537756/35f7cd1defc6/BLT.17.193375-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c92b/5537756/96a06d1423ec/BLT.17.193375-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c92b/5537756/d3b2acd9e5e0/BLT.17.193375-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c92b/5537756/edf7f37e14e7/BLT.17.193375-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c92b/5537756/95d1b253a485/BLT.17.193375-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c92b/5537756/35f7cd1defc6/BLT.17.193375-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c92b/5537756/96a06d1423ec/BLT.17.193375-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c92b/5537756/d3b2acd9e5e0/BLT.17.193375-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c92b/5537756/edf7f37e14e7/BLT.17.193375-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c92b/5537756/95d1b253a485/BLT.17.193375-F5.jpg

相似文献

1
Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis.去中心化的耐多药结核病护理:系统评价和荟萃分析。
Bull World Health Organ. 2017 Aug 1;95(8):584-593. doi: 10.2471/BLT.17.193375.
2
Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies.“直接观察治疗短程化疗加强版”(DOTS-Plus)方案下耐多药结核病的治疗效果:已发表研究的系统评价与荟萃分析
Infect Dis Poverty. 2017 Jan 17;6(1):7. doi: 10.1186/s40249-016-0214-x.
3
Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.移民人群中耐多药结核病治疗依从性:系统评价和荟萃分析。
BMC Med. 2018 Feb 22;16(1):27. doi: 10.1186/s12916-017-1001-7.
4
Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.埃塞俄比亚环境下的耐多药结核病及其与既往抗结核治疗史的关联:一项系统评价与荟萃分析
BMC Infect Dis. 2017 Mar 20;17(1):219. doi: 10.1186/s12879-017-2323-y.
5
Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis.较短疗程的耐多药或耐利福平结核病治疗方案的疗效与安全性:一项网状Meta分析
BMC Infect Dis. 2024 Oct 1;24(1):1087. doi: 10.1186/s12879-024-09960-3.
6
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
7
Psychological therapies for treatment-resistant depression in adults.成人难治性抑郁症的心理治疗
Cochrane Database Syst Rev. 2018 May 14;5(5):CD010558. doi: 10.1002/14651858.CD010558.pub2.
8
Antidepressants for depression in adults with HIV infection.用于感染HIV的成年抑郁症患者的抗抑郁药。
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD008525. doi: 10.1002/14651858.CD008525.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

引用本文的文献

1
The effects of decentralisation on patient and service outcomes: a case of the 2018 decentralisation of multidrug-resistant tuberculosis in Zambia.权力下放对患者和服务结果的影响:以赞比亚2018年耐多药结核病权力下放为例。
Arch Public Health. 2025 Jul 24;83(1):193. doi: 10.1186/s13690-025-01672-7.
2
Longitudinal phenotypic and genomic evidence revealing increased risk of drug resistance accumulation in tuberculosis patients in the counties of central China.纵向表型和基因组证据揭示中国中部各县结核病患者耐药性积累风险增加。
Microbiol Spectr. 2025 Aug 5;13(8):e0038025. doi: 10.1128/spectrum.00380-25. Epub 2025 Jun 23.
3

本文引用的文献

1
Cost-optimization in the treatment of multidrug resistant tuberculosis in Nigeria.尼日利亚耐多药结核病治疗中的成本优化
Trop Med Int Health. 2016 Feb;21(2):176-82. doi: 10.1111/tmi.12648. Epub 2015 Dec 18.
2
Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.住院率降低对南非耐多药结核病治疗费用的影响。
Int J Tuberc Lung Dis. 2015 Feb;19(2):172-8. doi: 10.5588/ijtld.14.0421.
3
Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.
Care-seeking and treatment pathways of multidrug-resistant tuberculosis patients: an analysis of real-world data from regional health information system in Ningbo City in Eastern China.
耐多药结核病患者的就医及治疗途径:来自中国东部宁波市区域卫生信息系统的真实世界数据分析
Ann Med. 2025 Dec;57(1):2496405. doi: 10.1080/07853890.2025.2496405. Epub 2025 Apr 21.
4
Clinical Features, Adverse Events and Treatment Outcomes of Multidrug/Rifampicin-resistant Tuberculosis in Children and Adolescents: An Eight-year Retrospective Cohort Study in Bandung, Indonesia.儿童和青少年耐多药/利福平耐药结核病的临床特征、不良事件及治疗结果:印度尼西亚万隆一项为期八年的回顾性队列研究
Pediatr Infect Dis J. 2025 Feb 1;44(2):143-150. doi: 10.1097/INF.0000000000004539. Epub 2024 Sep 23.
5
Drug-resistant tuberculosis care and treatment outcomes over the last 15 years in Ethiopia: Results from a mixed-method review of trends.过去 15 年在埃塞俄比亚的耐药结核病护理和治疗结果:趋势的混合方法综述结果。
PLoS One. 2024 Aug 26;19(8):e0306076. doi: 10.1371/journal.pone.0306076. eCollection 2024.
6
Opinion review of drug resistant tuberculosis in West Africa: tackling the challenges for effective control.西非耐药结核病意见综述:应对有效控制的挑战。
Front Public Health. 2024 May 16;12:1374703. doi: 10.3389/fpubh.2024.1374703. eCollection 2024.
7
Self-driven solutions and resilience adapted by people with drug-resistant tuberculosis and their caregivers in Bengaluru and Hyderabad, India: a qualitative study.印度班加罗尔和海得拉巴耐多药结核病患者及其照护者采用的自主驱动解决方案和适应能力:一项定性研究
Lancet Reg Health Southeast Asia. 2024 Feb 21;22:100372. doi: 10.1016/j.lansea.2024.100372. eCollection 2024 Mar.
8
Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in Lesotho.低体重指数可预测莱索托耐多药结核病患者痰培养转化和治疗结局。
Glob Health Action. 2024 Dec 31;17(1):2305930. doi: 10.1080/16549716.2024.2305930. Epub 2024 Feb 2.
9
Finding the missing many: improving Tuberculosis care in Kajiado county through active case finding and community approaches.寻找失踪者:通过主动病例发现和社区方法改善卡加多县的结核病护理。
BMC Public Health. 2024 Jan 10;24(1):144. doi: 10.1186/s12889-023-17631-2.
10
How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians.我们如何治疗药物敏感型肺结核:临床医生实用指南
Antibiotics (Basel). 2023 Dec 14;12(12):1733. doi: 10.3390/antibiotics12121733.
南非夸祖鲁-纳塔尔省耐多药结核病患者的社区护理与集中住院治疗对比
Int J Tuberc Lung Dis. 2015 Feb;19(2):163-71. doi: 10.5588/ijtld.14.0369.
4
Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis.基于社区的耐药结核病治疗项目的治疗结局:系统评价和荟萃分析。
BMC Infect Dis. 2014 Jun 17;14:333. doi: 10.1186/1471-2334-14-333.
5
Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.南非开普敦凯伊利沙地区基于社区的耐多药结核病治疗
Int J Tuberc Lung Dis. 2014 Apr;18(4):441-8. doi: 10.5588/ijtld.13.0742.
6
A systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis.抗多种药物耐药结核病的医院和门诊管理有效性的系统评价。
Am J Trop Med Hyg. 2013 Aug;89(2):271-80. doi: 10.4269/ajtmh.13-0004.
7
Effectiveness of a government-organized and hospital-initiated treatment for multidrug-resistant tuberculosis patients--a retrospective cohort study.政府组织、医院发起的耐多药结核病患者治疗的效果:一项回顾性队列研究。
PLoS One. 2013;8(2):e57719. doi: 10.1371/journal.pone.0057719. Epub 2013 Feb 25.
8
Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents.免费的结核病诊断和治疗还不够:来自三大洲的患者费用证据。
Int J Tuberc Lung Dis. 2013 Mar;17(3):381-7. doi: 10.5588/ijtld.12.0368.
9
Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.降低耐多药结核病治疗中断策略:系统评价和荟萃分析。
Int J Tuberc Lung Dis. 2013 Mar;17(3):299-307. doi: 10.5588/ijtld.12.0537. Epub 2012 Dec 4.
10
Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis.患者和项目因素对耐多药结核病治疗中停药的影响。
Int J Tuberc Lung Dis. 2012 Jul;16(7):955-60. doi: 10.5588/ijtld.11.0502. Epub 2012 May 7.